We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Snaps Up Biotech Firm Focused on Apoptosis
Pfizer Snaps Up Biotech Firm Focused on Apoptosis
February 24, 2005
Pfizer has inked a deal to acquire Idun Pharmaceuticals, a San Diego-based biopharmaceutical firm that owns more than 150 patents covering drug targets, new chemical entities, drug-screening assays, diagnostics and antibodies.